Effect of vachadi kwatha & lekhana basti in Medoroga(Dyslipidemia)

To Study the Effect of Vachadi Kwatha with & without Lekhana Basti in Management of Medoroga with special reference to Dyslipidemia - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067312

Enrollment

Registered

2024-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Classical sign and symptoms of Medoroga BMI 25 34 Kg/m2 Dearranged lipid profile As per National Cholesterol Education Program Guidelines

Exclusion criteria

Exclusion criteria: Age group less than 20 & more than 60 yrs Patient not fulfilling sign and symptoms of Medoroga as per classical text Subjective and Objective criteria not fulfilling BMI more than 35 Kg/m2 Very high ranges of lipid profile as per ATP III Classification (NCEP) Pregnant or lactating women Hypothyroidism, Endocrinopathies, DM-2 with complications Patient suffering from any severe systemic diseases

Design outcomes

Primary

Measure	Time frame
Improvement assess in terms of BMI and lipid profile on first second and third follow upTimepoint: Status of patient assess at zero day and after first follow up after second follow up and after complete treatment that is third follow up ( Day 0,15,30,45)	—

Secondary

Measure	Time frame
Improvement in Sign & Symptoms of Medoroga (Dyslipidemia) patient in three follow up under 45 daysTimepoint: Evalutaion before treatment Day zero & after third follow up day 45	—

Countries

India

Contacts

Public ContactProf Sunanda R Pedhekar

Faculty of Ayurveda, Institute of Medical Science, Banaras Hindu University

drsrpedhekar@gmail.com9423241800

Outcome results